Sequent Scientific is India’s leading animal health company, with presence in 5+ continents across 100 countries. Sequent Scientific Limited provides a wide-ranging portfolio of animal health products, including Finished Dose Formulations, APIs, as well as analytical services to the pharmaceutical and life sciences industries.
Financial Results:
Sequent Scientific Ltd reported Revenues for Q2FY24 of ₹345.97 Crores up from ₹337.61 Crore year on year, a rise of 2.48%.
Total Expenses for Q2FY24 of ₹358.78 Crores up from ₹356.24 Crores year on year, a rise of 0.71%.
Consolidated Net Profit of -₹6.88 Crores from -₹4.44 Crores in the same quarter of the previous year.
The Earnings per Share is -₹0.34, from -₹0.15 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.